C11H13NO
Neat
175.23
-20°C
Room Temperature
158930-17-7; Frovatriptan succinate hydrate; Frovatriptan Succinate monohydrate; Frovelan; Migard; VML 251; VML-251; SB 209509-AX; D28J6W18HY; DTXSID2049056; SB 209509 AX; SB-209509-AX; NSC-760422; DTXCID7028982; (+)-(R)-5, 6, 7, 8-Tetrahydro-6-(methylamino)carbazole-3-carboxamide succinate (1:1), monohydrate; RefChem:56376; VML251; DTXCID8089034; 1H-Carbazole-6-carboxamide, 2, 3, 4, 9-tetrahydro-3-(methylamino)-, (3R)- and Butanedioate(1:1); 36K05YF32G
butanedioic acid;(6R)-6-(methylamino)-6, 7, 8 and 9-tetrahydro-5H-carbazole-3-carboxamide;hydrate
InChI=1S/C14H17N3O.C4H6O4.H2O/c1-16-9-3-5-13-11(7-9)10-6-8(14(15)18)2-4-12(10)17-13;5-3(6)1-2-4(7)8;/h2,4,6,9,16-17H,3,5,7H2,1H3,(H2,15,18);1-2H2,(H,5,6)(H,7,8);1H2/t9-;;/m1../s1